|
Side effects in each treatment group. |
||
| QT |
OAR |
|
|
|
||
| Total patients |
35 (64%) * |
20 (44%) * |
| Dyspepsia |
||
| + |
17 |
8 |
| +++ |
1 |
1 |
| Taste-sensation alteration |
||
| + |
12 |
5 |
| +++ |
2 |
|
| Dizziness |
||
| + |
13 |
4 |
| +++ |
1 |
|
| Diarrhoea |
||
| + |
10 |
6 |
| +++ |
1 |
|
| Nausea/Vomiting |
||
| + |
10 |
5 |
| +++ |
3 |
1 |
| Loss of appetite |
||
| + |
9 |
6 |
| +++ |
2 |
|
| Cephalea |
||
| + |
8 |
6 |
| +++ |
1 |
1 |
| Odynophagia |
||
| + |
4 (2 candidiasis) |
|
| +++ |
||
| Asthenia/tiredness |
||
| + |
2 |
3 |
| +++ |
||
| Total episodes |
85 |
43 |
| Total episodes +++ |
11 |
3 |
|
* p 0.042 +: : mild/moderate +++: : severe | ||
Navarro-Jarabo et al. BMC Gastroenterology 2007 7:31 doi:10.1186/1471-230X-7-31 |
||